Generics - Biotechnology, Pharmaceutical

Filter

Popular Filters

1 to 25 of 30 results

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData

10-05-2013

The rising prices of new cancer drugs are resulting in an increasing cost burden for patients and health…

BiotechnologyGenericsGlobalMarkets & MarketingOncologyPharmaceuticalPricing

EMA focuses on new legislation, increased efficiency and transparency in 2013 work program

13-03-2013

The European Medicines Agency has published its work program for 2013. This year, the Agency's priorities…

BiotechnologyEuropeGenericsPharmaceuticalRegulation

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

US pharma organizations work together to foster supply chain security and integrity

31-01-2013

The 100th meeting of the USA-based National Conference of Pharmaceutical Organizations (NCPO) - consisting…

BiotechnologyGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceutical

Indian pharmaceuticals market led by Ranbaxy in terms of revenue

31-01-2013

The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

2012 again a bumper year for Pharma M&A, but values well down

09-01-2013

The year 2012 was again a bumper year for merger and acquisition activity in the global pharmaceutical,…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2012

07-01-2013

Details for the 131 M&A announcements in 2012 recorded by The Pharma Letter are provided in the full…

BiotechGenericsMergers & AcquisitionsPharmaceutical

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

04-01-2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

American Capital commits $212 million to acquire Cambridge Major Laboratories

03-01-2013

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

Sales of antiretroviral agents for HIV will decline slightly over next decade

18-12-2012

Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

EMA 2013 work program and budget endorsed by management board

18-12-2012

The European Medicines Agency's Management Board revealed yesterday that, at its meeting on December…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulation

Biopharmaceuticals promise to boost downstream processing in Asia

04-11-2012

Global contract manufacturing organizations (CMOs) are set to steadily become more and more popular,…

Asia-PacificBiotechnologyGenericsPharmaceuticalProduction

Medicines for normal aging conditions overtakes costs of treating most chronic diseases; Express Scripts

30-10-2012

In the USA, prescription-drug treatment regimens for conditions that are a normal part of aging are now…

BiotechnologyFinancialGenericsHealthcareNorth AmericaPharmaceutical

EMA expects lower rate of generic applications; Issues guidelines on schizophrenia and MS

11-10-2012

In its mid-year report for 2012, the European Medicines Agency's management board yesterday provided…

BiotechnologyEuropeGenericsNeurologicalPharmaceuticalRegulationResearch

FDA approves pediatric Afinitor from Novartis and Teva's tbo-filgrastim

30-08-2012

The US Food and Drug Administration yesterday approved Swiss drug major Novartis' (NOVN: VX) Afinitor…

AfinitorBiotechnologyGenericsNorth AmericaNovartisOncologyPharmaceuticalRegulationSicor Biotechtbo-filgrastimTeva Pharmaceutical Industries

Pharma industry calls for broad-based cooperation to fight on-line sales of counterfeit medicines

24-07-2012

The global pharmaceutical industry unveiled recommendations this week to tackle the growing public health…

BiotechnologyGenericsGlobalMarkets & MarketingPharmaceuticalRegulation

UK's NICE launches new medicines advisory service

15-07-2012

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) last Friday launched…

Antibiotics and Infectious diseasesAstellas PharmaBiotechnologyDificlirEuropeGenericsPharmaceuticalRegulation

Global medicines spending set to rebound, reaching nearly $1.2 trillion by 2016, says IMS

13-07-2012

Following several years of slowing growth, the global market for medicines is poised to rebound from…

BiotechnologyGenericsGlobalHealthcareMarkets & MarketingPatentsPharmaceutical

1 to 25 of 30 results

Back to top